Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F d'Oleire

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer|June 1, 1993
Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 studyR Ladenstein, J Treuner, E Koscielniak, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 14, 1997
Lack of thermal enhancement for taxanes in vitroR C Rietbroek, D M Katschinski, M H Reijers, et al.
Cancer Research|October 15, 1994
Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratomaG J Wiedemann, F d'Oleire, E Knop, et al.
Cancer Letters|November 6, 1995
Cytokine induction by 41.8 degrees C whole body hyperthermiaH I Robins, M Kutz, G J Wiedemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, J D Cohen, C L Schmitt, et al.
Neuropharmacology|October 27, 2018
Habenula-prefrontal resting-state connectivity in reactive aggressive men - A pilot studyG Gan, A Zilverstand, M A Parvaz, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1996
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia]G J Wiedemann, H I Robins, D M Katschinski, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermiaH I Robins, D M Katschinski, W Longo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, D Rushing, M Kutz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer|June 1, 1993
Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 studyR Ladenstein, J Treuner, E Koscielniak, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 14, 1997
Lack of thermal enhancement for taxanes in vitroR C Rietbroek, D M Katschinski, M H Reijers, et al.
Cancer Research|October 15, 1994
Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratomaG J Wiedemann, F d'Oleire, E Knop, et al.
Cancer Letters|November 6, 1995
Cytokine induction by 41.8 degrees C whole body hyperthermiaH I Robins, M Kutz, G J Wiedemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, J D Cohen, C L Schmitt, et al.
Neuropharmacology|October 27, 2018
Habenula-prefrontal resting-state connectivity in reactive aggressive men - A pilot studyG Gan, A Zilverstand, M A Parvaz, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1996
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia]G J Wiedemann, H I Robins, D M Katschinski, et al.
Cancer Chemotherapy and Pharmacology|April 1, 1999
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermiaH I Robins, D M Katschinski, W Longo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patientsH I Robins, D Rushing, M Kutz, et al.
Pageof 2